AtriCure Dividends
| ATRC Stock | USD 31.26 0.38 1.20% |
The current year's Dividend Paid And Capex Coverage Ratio is expected to grow to 6.65, whereas Dividends Paid is forecasted to decline to 0.00. AtriCure's past performance could be the main factor of why investors trade AtriCure stock today. Investors should clearly understand every aspect of the AtriCure dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest AtriCure's dividend schedule and payout information. AtriCure dividends can also provide a clue to the current valuation of AtriCure.
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | 6.34 | 6.65 |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in AtriCure must own a stock before its ex-dividend date to receive its next dividend.
AtriCure Dividends Paid Over Time
Today, most investors in AtriCure Stock are looking for potential investment opportunities by analyzing not only static indicators but also various AtriCure's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of AtriCure dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Will Health Care Equipment & Supplies sector continue expanding? Could AtriCure diversify its offerings? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AtriCure data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.24) | Revenue Per Share | Quarterly Revenue Growth 0.131 | Return On Assets | Return On Equity |
Understanding AtriCure requires distinguishing between market price and book value, where the latter reflects AtriCure's accounting equity. The concept of intrinsic value - what AtriCure's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push AtriCure's price substantially above or below its fundamental value.
Understanding that AtriCure's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AtriCure represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, AtriCure's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.